Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Remimazolam With Flumazenil vs. Propofol TIVA During RFCA for Atrial Fibrillation

NCT05397886 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05397886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05397886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Remimazolam With Flumazenil vs. Propofol TIVA During RFCA for Atrial Fibrillation
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 2, 2022
Completion date
April 25, 2023
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recovery